AZD0947 Uses, Dosage, Side Effects and more
AZD0947 is a K+ channel opener, which was under investigation by AstraZeneca for the treatment of overactive bladder. As of March 2003, the drug was in phase II trials; however, as of October 2004, it no longer appeared on the company’s development pipeline.
AZD0947 is a K+ channel opener.
| Trade Name | AZD0947 |
| Generic | AZD0947 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Intended for the treatment of urinary incontinence.
